Knight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil

MONTREAL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., GUD ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a marketing authorization application to ANVISA, the Brazilian health…#montreal #gud #panamerican #exusa #brazilian #unitedmedicalltda #anvisa #colombia #mexico #knight
Source: Reuters: Health - Category: Consumer Health News Source Type: news